JP2009504681A5 - - Google Patents

Download PDF

Info

Publication number
JP2009504681A5
JP2009504681A5 JP2008526290A JP2008526290A JP2009504681A5 JP 2009504681 A5 JP2009504681 A5 JP 2009504681A5 JP 2008526290 A JP2008526290 A JP 2008526290A JP 2008526290 A JP2008526290 A JP 2008526290A JP 2009504681 A5 JP2009504681 A5 JP 2009504681A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008526290A
Other languages
Japanese (ja)
Other versions
JP2009504681A (en
Filing date
Publication date
Priority claimed from US11/206,903 external-priority patent/US8076288B2/en
Priority claimed from US11/301,744 external-priority patent/US7723471B2/en
Application filed filed Critical
Priority claimed from PCT/US2006/031724 external-priority patent/WO2007022123A2/en
Publication of JP2009504681A publication Critical patent/JP2009504681A/en
Publication of JP2009504681A5 publication Critical patent/JP2009504681A5/ja
Pending legal-status Critical Current

Links

JP2008526290A 2005-08-11 2006-08-11 Hybrid polypeptides with selectable properties Pending JP2009504681A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US20166405A 2005-08-11 2005-08-11
US11/206,903 US8076288B2 (en) 2004-02-11 2005-08-17 Hybrid polypeptides having glucose lowering activity
US11/301,744 US7723471B2 (en) 2004-02-11 2005-12-12 Pancreatic polypeptide family motifs, polypeptides and methods comprising the same
PCT/US2006/031724 WO2007022123A2 (en) 2005-08-11 2006-08-11 Hybrid polypeptides with selectable properties

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2011137014A Division JP5373855B2 (en) 2005-08-11 2011-06-21 Hybrid polypeptides with selectable properties

Publications (2)

Publication Number Publication Date
JP2009504681A JP2009504681A (en) 2009-02-05
JP2009504681A5 true JP2009504681A5 (en) 2009-12-17

Family

ID=39662713

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008526290A Pending JP2009504681A (en) 2005-08-11 2006-08-11 Hybrid polypeptides with selectable properties

Country Status (7)

Country Link
JP (1) JP2009504681A (en)
KR (1) KR101399178B1 (en)
CN (1) CN101296942A (en)
EA (1) EA014647B1 (en)
IL (1) IL188937A0 (en)
MX (1) MX2008002028A (en)
ZA (1) ZA200801138B (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010118384A2 (en) * 2009-04-10 2010-10-14 Amylin Pharmaceuticals, Inc. Amylin agonist compounds for estrogen-deficient mammals
EP2504021A4 (en) * 2009-11-23 2013-05-15 Amylin Pharmaceuticals Llc Polypeptide conjugate
GB201001333D0 (en) * 2010-01-27 2010-03-17 Imp Innovations Ltd Novel compounds and their effects on feeding behaviour
MX343360B (en) * 2010-04-27 2016-11-03 Zealand Pharma As Peptide conjugates of glp-1 receptor agonists and gastrin and their use.
RU2552221C2 (en) * 2010-07-15 2015-06-10 Общество С Ограниченной Ответственностью "Научно-Производственная Фирма "Материа Медика Холдинг" Method of treating obesity and accompanying metabolic disorders and medication for treating obesity and accompanying metabolic disorders
WO2012162547A2 (en) * 2011-05-25 2012-11-29 Amylin Pharmaceuticals, Inc. Long duration dual hormone conjugates
TWI674270B (en) * 2012-12-11 2019-10-11 英商梅迪繆思有限公司 Glucagon and glp-1 co-agonists for the treatment of obesity
JP2017532292A (en) * 2014-08-11 2017-11-02 オルバニー メディカル カレッジ Myristoylated leptin-related peptides and uses thereof
KR101689803B1 (en) * 2015-11-17 2016-12-27 고려대학교 산학협력단 Composition for preventing or treating of diabetes or obesity containing Apelin-16
US11034745B2 (en) * 2016-01-04 2021-06-15 Adepthera Llc Superagonist polypeptide analogs of adrenomedullin and intermedin peptide hormones
JP6889432B2 (en) * 2016-04-28 2021-06-18 学校法人甲南学園 Resin-fixed peptide
SG11201901393VA (en) * 2016-09-02 2019-03-28 Univ Illinois Kif13b-derived peptide and method of inhibiting angiogenesis
JP7202011B2 (en) * 2017-09-13 2023-01-11 キッズウェル・バイオ株式会社 Anti-RAMP2 antibody
US10875902B2 (en) 2018-04-25 2020-12-29 Janssen Pharmaceutica Nv Glucagon like peptide 1 (GLP-1) fusion peptide coupled cyclic peptide tyrosine tyrosine conjugates and uses thereof
TW202014433A (en) * 2018-04-25 2020-04-16 比利時商健生藥品公司 Glucagon like peptide 1 (glp-1) fusion peptide coupled cyclic peptide tyrosine tyrosine conjugates and uses thereof
KR102116944B1 (en) * 2019-09-23 2020-05-29 주식회사 차메디텍 Novel peptide derivatives having melanin production inhibitory activity, pharmaceutically acceptable salts thereof, and composition for inhibiting melanin production comprising the same
CN115960258B (en) * 2022-09-30 2024-01-12 广西医科大学附属肿瘤医院 GLP-1/glucon/Y 2 Receptor triple agonists and uses thereof

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5739106A (en) * 1995-06-07 1998-04-14 Rink; Timothy J. Appetite regulating compositions
EP0910578A2 (en) * 1996-01-19 1999-04-28 The Board Of Regents, The University Of Texas System Recombinant expression of proteins from secretory cell lines
AU1159897A (en) 1996-11-13 1998-06-03 University Of Cincinnati, The Analogs of peptide yy and uses thereof
PL194159B1 (en) * 1996-12-20 2007-05-31 Amgen Inc Fusion-type protein ob - compositions and methods
US6506724B1 (en) * 1999-06-01 2003-01-14 Amylin Pharmaceuticals, Inc. Use of exendins and agonists thereof for the treatment of gestational diabetes mellitus
US6528486B1 (en) * 1999-07-12 2003-03-04 Zealand Pharma A/S Peptide agonists of GLP-1 activity
EP1246638B2 (en) * 2000-01-10 2014-07-30 Amylin Pharmaceuticals, Inc. Use of exendins and agonists thereof for the treatment of hypertriglyceridemia
WO2002046227A2 (en) * 2000-12-07 2002-06-13 Eli Lilly And Company Glp-1 fusion proteins
EP2275117B1 (en) * 2001-07-31 2016-10-26 The Government of the United States of America, as represented by the Secretary of the Department of Health and Human Services GLP-1, exendin-4, peptide analogs and uses thereof
US7192922B2 (en) * 2002-11-19 2007-03-20 Allegheny-Singer Research Institute Method of treating left ventricular dysfunction
US7166575B2 (en) 2002-12-17 2007-01-23 Nastech Pharmaceutical Company Inc. Compositions and methods for enhanced mucosal delivery of peptide YY and methods for treating and preventing obesity
WO2004056313A2 (en) * 2002-12-17 2004-07-08 Amylin Pharmaceuticals, Inc. Prevention and treatment of cardiac arrhythmias
US20070027073A1 (en) * 2003-04-08 2007-02-01 Menachem Rubinstein Long-acting derivatives of pyy agonists
EP2417980A1 (en) * 2004-02-11 2012-02-15 Amylin Pharmaceuticals Inc. Hybrid polypeptides with selectable properties

Similar Documents

Publication Publication Date Title
BRPI0720064A2 (en)
BRMU8603216U8 (en)
BRPI0715824A8 (en)
JP2009504681A5 (en)
BRPI0713487A2 (en)
BR122016023444A2 (en)
BRPI0708307B8 (en)
CH2121272H1 (en)
AT504380A8 (en)
BY9789C1 (en)
CN300727443S (zh) 蓄电池(ev22)
CN300731999S (zh) 包装盒(美蕾兹1)
CN300731986S (zh) 酒包装箱(四)
CN300730207S (zh) 用于瓷砖的压机
CN300729985S (zh) 蓝牙耳机(gk-202)
CN300725924S (zh) 童装(3789)
CN300729822S (zh) 婴儿推车(yk-727)
CN300729381S (zh) 饮品罐(洋酒伴侣)
CN300729208S (zh) 调味品容器座(3)
CN300728508S (zh) 骨灰盒(sc-5-c1-4)
CN300725925S (zh) 童装(3791)
CN300725915S (zh) 童装(3728)
CN300728170S (zh) 浴室柜(vg-324)
CN300727915S (zh) 标贴(三)
CN300725926S (zh) 童装(3793)